$CNMD
CONMED Corp

2013 Q4 Form 10-Q Financial Statement

#000081695613000011 Filed on October 28, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q3
Revenue $203.4M $179.3M $181.9M
YoY Change 1.09% -1.45% 5.25%
Cost Of Revenue $95.10M $83.83M $83.97M
YoY Change 4.05% -0.17% 3.03%
Gross Profit $111.4M $95.42M $97.91M
YoY Change 3.83% -2.54% 7.23%
Gross Profit Margin 54.76% 53.23% 53.83%
Selling, General & Admin $83.90M $73.48M $74.06M
YoY Change 5.01% -0.79% 8.36%
% of Gross Profit 75.32% 77.0% 75.64%
Research & Development $6.400M $7.108M $7.077M
YoY Change -7.25% 0.44% 0.8%
% of Gross Profit 5.75% 7.45% 7.23%
Depreciation & Amortization $12.40M $11.70M $11.70M
YoY Change 5.08% 0.0% 21.88%
% of Gross Profit 11.13% 12.26% 11.95%
Operating Expenses $85.50M $86.62M $83.80M
YoY Change -1.38% 3.37% 11.18%
Operating Profit $25.89M $8.805M $14.11M
YoY Change 25.78% -37.62% -11.46%
Interest Expense -$1.500M $1.382M $1.345M
YoY Change 7.14% 2.75% -19.46%
% of Operating Profit -5.79% 15.7% 9.53%
Other Income/Expense, Net
YoY Change
Pretax Income $14.70M $7.423M $12.77M
YoY Change -5.77% -41.87% -2.82%
Income Tax $4.500M $1.736M $3.449M
% Of Pretax Income 30.61% 23.39% 27.01%
Net Earnings $10.23M $5.687M $9.320M
YoY Change -6.15% -38.98% 13.51%
Net Earnings / Revenue 5.03% 3.17% 5.12%
Basic Earnings Per Share $0.37 $0.21 $0.33
Diluted Earnings Per Share $0.36 $0.20 $0.32
COMMON SHARES
Basic Shares Outstanding 27.61M shares 27.52M shares 28.44M shares
Diluted Shares Outstanding 27.83M shares 28.72M shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $54.40M $49.80M $19.80M
YoY Change 129.54% 151.52% -50.38%
Cash & Equivalents $54.44M $49.83M $19.82M
Short-Term Investments
Other Short-Term Assets $30.20M $29.10M $25.40M
YoY Change 12.27% 14.57% 3.67%
Inventory $143.2M $151.0M $165.3M
Prepaid Expenses
Receivables $140.4M $130.6M $132.9M
Other Receivables $3.800M $3.400M $1.300M
Total Short-Term Assets $372.1M $363.9M $344.7M
YoY Change 6.66% 5.58% -6.87%
LONG-TERM ASSETS
Property, Plant & Equipment $139.0M $138.5M $139.8M
YoY Change -0.04% -0.91% 0.14%
Goodwill $248.4M $248.5M $256.8M
YoY Change -0.03% -3.24% -12.94%
Intangibles $319.4M $322.7M $192.7M
YoY Change -4.41% 67.44% 3.98%
Long-Term Investments
YoY Change
Other Assets $11.50M $10.30M $154.8M
YoY Change 40.24% -93.35% 1601.1%
Total Long-Term Assets $718.4M $720.0M $744.1M
YoY Change -1.59% -3.24% 18.29%
TOTAL ASSETS
Total Short-Term Assets $372.1M $363.9M $344.7M
Total Long-Term Assets $718.4M $720.0M $744.1M
Total Assets $1.091B $1.084B $1.089B
YoY Change 1.08% -0.45% 8.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $27.45M $27.24M $31.94M
YoY Change 16.2% -14.72% 53.84%
Accrued Expenses $33.40M $26.10M $27.10M
YoY Change -0.3% -3.69% 4.63%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.140M $1.093M $1.009M
YoY Change 8.57% 8.33% -99.39%
Total Short-Term Liabilities $111.3M $100.9M $125.5M
YoY Change -11.14% -19.65% -46.03%
LONG-TERM LIABILITIES
Long-Term Debt $214.4M $224.0M $168.4M
YoY Change 33.35% 33.0% 1747.1%
Other Long-Term Liabilities $45.29M $59.61M $86.05M
YoY Change -47.72% -30.72% 216.69%
Total Long-Term Liabilities $259.7M $283.6M $254.5M
YoY Change 4.97% 11.45% 601.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $111.3M $100.9M $125.5M
Total Long-Term Liabilities $259.7M $283.6M $254.5M
Total Liabilities $484.2M $491.7M $486.3M
YoY Change 2.61% 1.1% 24.88%
SHAREHOLDERS EQUITY
Retained Earnings $395.9M $391.2M $371.3M
YoY Change 4.76% 5.36% -2.19%
Common Stock $313.0K $313.0K $313.0K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $98.75M $96.71M $64.90M
YoY Change 45.3% 49.02% -16.85%
Treasury Stock Shares
Shareholders Equity $606.3M $592.2M $602.4M
YoY Change
Total Liabilities & Shareholders Equity $1.091B $1.084B $1.089B
YoY Change 1.08% -0.45% 8.97%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income $10.23M $5.687M $9.320M
YoY Change -6.15% -38.98% 13.51%
Depreciation, Depletion And Amortization $12.40M $11.70M $11.70M
YoY Change 5.08% 0.0% 21.88%
Cash From Operating Activities $27.30M $30.40M $28.00M
YoY Change -19.47% 8.57% -23.29%
INVESTING ACTIVITIES
Capital Expenditures -$4.800M -$5.400M -$4.400M
YoY Change -12.73% 22.73% 7.32%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$18.70M
YoY Change -100.0% -100.0%
Cash From Investing Activities -$4.800M -$5.400M -$23.10M
YoY Change -32.39% -76.62% 463.41%
FINANCING ACTIVITIES
Cash Dividend Paid $4.300M
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -17.50M -14.60M -600.0K
YoY Change -16.27% 2333.33% -96.03%
NET CHANGE
Cash From Operating Activities 27.30M 30.40M 28.00M
Cash From Investing Activities -4.800M -5.400M -23.10M
Cash From Financing Activities -17.50M -14.60M -600.0K
Net Change In Cash 5.000M 10.40M 4.300M
YoY Change -15.25% 141.86% -75.14%
FREE CASH FLOW
Cash From Operating Activities $27.30M $30.40M $28.00M
Capital Expenditures -$4.800M -$5.400M -$4.400M
Free Cash Flow $32.10M $35.80M $32.40M
YoY Change -18.53% 10.49% -20.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
27236000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
23622000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
139124000 USD
CY2013Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
130589000 USD
CY2013Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
311000 USD
CY2012Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2706000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-27581000 USD
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-26956000 USD
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
400000 shares
CY2013Q3 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P27Y
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
324322000 USD
CY2013Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
324403000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
20752000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
21840000 USD
CY2012Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3429000 USD
CY2013Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3353000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9080000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10291000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
400000 shares
CY2013Q3 us-gaap Assets
Assets
1083925000 USD
CY2012Q4 us-gaap Assets
Assets
1078849000 USD
CY2013Q3 us-gaap Assets Current
AssetsCurrent
363916000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
348893000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23720000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49831000 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19819000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26048000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6229000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
26111000 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.45
CY2012Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2013Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.45
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31299194 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31299194 shares
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
313000 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
313000 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7583000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
26337000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
28929000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10197000 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
7583000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
26337000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
28929000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
10197000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
267340000 USD
CY2012Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
83972000 USD
CY2013Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
83831000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
258240000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
11752000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
6802000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
11931000 USD
CY2013Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
12124000 USD
CY2013Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
1183000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
1057000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
99199000 USD
CY2013Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
107187000 USD
CY2013Q3 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-732000 USD
CY2012Q3 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-731000 USD
us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-2195000 USD
us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-2195000 USD
CY2013Q1 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
7500000 USD
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
3394000 USD
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
3907000 USD
CY2013Q3 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
1302000 USD
CY2012Q3 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
1131000 USD
CY2012Q3 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
860000 USD
CY2013Q3 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
785000 USD
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
2579000 USD
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
2356000 USD
CY2013Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
284000 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
852000 USD
CY2012Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
525000 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
1575000 USD
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
208000 USD
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
195000 USD
CY2013Q3 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
69000 USD
CY2012Q3 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
65000 USD
us-gaap Depreciation
Depreciation
13701000 USD
us-gaap Depreciation
Depreciation
14018000 USD
CY2013Q3 us-gaap Derivative Assets
DerivativeAssets
725000 USD
CY2012Q4 us-gaap Derivative Assets
DerivativeAssets
457000 USD
CY2013Q3 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
-1664000 USD
CY2012Q4 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
-1942000 USD
CY2013Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
2389000 USD
CY2012Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
2399000 USD
CY2012Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
4272000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.93
CY2013Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
4128000 USD
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.05
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.91
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-974000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-213000 USD
CY2013Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
26149000 USD
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
33511000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
102717000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
93637000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
13006000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
13409000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
12446000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
12503000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
12515000 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
12618000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
700000 USD
CY2012Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1000000 USD
CY2013Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
900000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-700000 USD
CY2013Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2012Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-263000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2013Q3 us-gaap Goodwill
Goodwill
248502000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
248502000 USD
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-8319000 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
95424000 USD
us-gaap Gross Profit
GrossProfit
301022000 USD
CY2012Q3 us-gaap Gross Profit
GrossProfit
97913000 USD
us-gaap Gross Profit
GrossProfit
298556000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
43861000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
7423000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
35933000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
12769000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14277000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10221000 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1736000 USD
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3449000 USD
CY2013Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
3388000 USD
CY2012Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2897000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2019000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1693000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8811000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6910000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-3262000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-7996000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-7352000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-5235000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2436000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5581000 USD
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-27926000 USD
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-31679000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2636000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2723000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-9171000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-10781000 USD
CY2013Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
425415000 USD
CY2012Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
427822000 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
334185000 USD
CY2013Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
322698000 USD
CY2013Q3 us-gaap Interest Expense
InterestExpense
1382000 USD
us-gaap Interest Expense
InterestExpense
4333000 USD
us-gaap Interest Expense
InterestExpense
4131000 USD
CY2012Q3 us-gaap Interest Expense
InterestExpense
1345000 USD
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
96884000 USD
CY2013Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
93100000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
156228000 USD
CY2013Q3 us-gaap Inventory Net
InventoryNet
150995000 USD
CY2012Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
45115000 USD
CY2013Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
41697000 USD
CY2013Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
16198000 USD
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
14229000 USD
us-gaap Legal Fees
LegalFees
1555000 USD
CY2013Q3 us-gaap Legal Fees
LegalFees
1475000 USD
us-gaap Legal Fees
LegalFees
2211000 USD
CY2012Q3 us-gaap Legal Fees
LegalFees
0 USD
CY2012Q4 us-gaap Liabilities
Liabilities
471851000 USD
CY2013Q3 us-gaap Liabilities
Liabilities
491693000 USD
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1083925000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1078849000 USD
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
100879000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
125214000 USD
CY2013Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1093000 USD
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1050000 USD
CY2013Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
224017000 USD
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
160802000 USD
us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Operations</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CONMED Corporation (&#8220;CONMED&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221; or &#8220;us&#8221;) is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures and monitoring.&#160;&#160;The Company&#8217;s products are used by surgeons and physicians in a variety of specialties including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology.</font></div></div>
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
32294000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13762000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13552000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-98812000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
53638000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
61263000 USD
us-gaap Operating Expenses
OperatingExpenses
250362000 USD
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
83799000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
86619000 USD
us-gaap Operating Expenses
OperatingExpenses
260695000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
48194000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
40327000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
14114000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
8805000 USD
CY2012Q4 us-gaap Other Assets
OtherAssets
7171000 USD
CY2013Q3 us-gaap Other Assets
OtherAssets
9121000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-2410000 USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-1607000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
96000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-2876000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3845000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-854000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
848000 USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2034000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1373000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1383000 USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-450000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-461000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
6421000 USD
CY2012Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
2658000 USD
CY2013Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
4608000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
8514000 USD
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
64325000 USD
CY2013Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
46090000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
86636000 USD
CY2013Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
59610000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
44729000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
-3339000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1725000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
8590000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
12568000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15969000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13552000 USD
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
16989000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14993000 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
64000000 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
80000000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
13027000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
9414000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
2975000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
5533000 USD
CY2013Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
3019000 USD
CY2012Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
3661000 USD
CY2011Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
3618000 USD
CY2012Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
3636000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
2927000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
3093000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
2310000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
3136000 USD
us-gaap Profit Loss
ProfitLoss
29584000 USD
CY2013Q3 us-gaap Profit Loss
ProfitLoss
5687000 USD
us-gaap Profit Loss
ProfitLoss
25712000 USD
CY2012Q3 us-gaap Profit Loss
ProfitLoss
9320000 USD
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
138505000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
139041000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
227000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
515000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
475000 USD
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
53588000 USD
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
0 USD
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7077000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19393000 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7108000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21364000 USD
us-gaap Restructuring Charges
RestructuringCharges
2965000 USD
CY2013Q3 us-gaap Restructuring Reserve
RestructuringReserve
3746000 USD
CY2012Q4 us-gaap Restructuring Reserve
RestructuringReserve
4120000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
377907000 USD
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
391179000 USD
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
179255000 USD
CY2012Q3 us-gaap Sales Revenue Net
SalesRevenueNet
181885000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
559262000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
565896000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
222577000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
228375000 USD
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
74064000 USD
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
73476000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4102000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4115000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
606998000 USD
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
592232000 USD
CY2013Q3 us-gaap Treasury Stock Number Of Shares Held
TreasuryStockNumberOfSharesHeld
3716981 shares
CY2012Q4 us-gaap Treasury Stock Number Of Shares Held
TreasuryStockNumberOfSharesHeld
2925801 shares
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
67963000 USD
CY2013Q3 us-gaap Treasury Stock Value
TreasuryStockValue
96707000 USD
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
367000 shares
CY2012Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
283000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
356000 shares
CY2013Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
316000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28111000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28621000 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27834000 shares
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28721000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27744000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28265000 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27518000 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28438000 shares
CY2013Q3 cnmd Excise Tax Medical
ExciseTaxMedical
1427000 USD
cnmd Excise Tax Medical
ExciseTaxMedical
0 USD
CY2012Q3 cnmd Excise Tax Medical
ExciseTaxMedical
0 USD
cnmd Excise Tax Medical
ExciseTaxMedical
4413000 USD
CY2012Q4 cnmd Goodwill As Reported
GoodwillAsReported
256821000 USD
CY2012Q1 cnmd Joint Development And Distribution Agreement Conditional Payment Amount
JointDevelopmentAndDistributionAgreementConditionalPaymentAmount
84000000 USD
CY2013Q3 cnmd Joint Development And Distribution Agreement Conditional Payment Amount Accrued
JointDevelopmentAndDistributionAgreementConditionalPaymentAmountAccrued
50000000 USD
CY2012Q1 cnmd Joint Development And Distribution Agreement Conditional Payment Period
JointDevelopmentAndDistributionAgreementConditionalPaymentPeriod
P4Y
CY2012Q1 cnmd Joint Development And Distribution Agreement Up Front Payment
JointDevelopmentAndDistributionAgreementUpFrontPayment
63000000 USD
cnmd Payments For Contingent Payments
PaymentsForContingentPayments
34000000 USD
cnmd Payments For Contingent Payments
PaymentsForContingentPayments
0 USD
cnmd Payments Related To Distribution Agreement
PaymentsRelatedToDistributionAgreement
0 USD
cnmd Payments Related To Distribution Agreement
PaymentsRelatedToDistributionAgreement
82843000 USD
CY2013Q3 cnmd Product Liability Contingency Insurance Aggregate Annual Amount
ProductLiabilityContingencyInsuranceAggregateAnnualAmount
25000000 USD
CY2013Q3 cnmd Product Liability Contingency Insurance Amount Per Incident
ProductLiabilityContingencyInsuranceAmountPerIncident
25000000 USD
cnmd Product Warranty Accrual Term
ProductWarrantyAccrualTerm
P1Y
cnmd Restructuring Charges Administrative
RestructuringChargesAdministrative
3444000 USD
CY2012Q3 cnmd Restructuring Charges Administrative
RestructuringChargesAdministrative
1940000 USD
CY2013Q3 cnmd Restructuring Charges Administrative
RestructuringChargesAdministrative
3133000 USD
cnmd Restructuring Charges Administrative
RestructuringChargesAdministrative
6303000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000816956
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27614196 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
CONMED CORP

Files In Submission

Name View Source Status
0000816956-13-000011-index-headers.html Edgar Link pending
0000816956-13-000011-index.html Edgar Link pending
0000816956-13-000011.txt Edgar Link pending
0000816956-13-000011-xbrl.zip Edgar Link pending
cnmd-20130930.xml Edgar Link completed
cnmd-20130930.xsd Edgar Link pending
cnmd-20130930_cal.xml Edgar Link unprocessable
cnmd-20130930_def.xml Edgar Link unprocessable
cnmd-20130930_lab.xml Edgar Link unprocessable
cnmd-20130930_pre.xml Edgar Link unprocessable
cnmd9301310-q.htm Edgar Link pending
cnmd93013ex311.htm Edgar Link pending
cnmd93013ex312.htm Edgar Link pending
cnmd93013ex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending